Format

Send to

Choose Destination
Cardiol Ther. 2019 Dec;8(2):211-228. doi: 10.1007/s40119-019-00152-8. Epub 2019 Oct 23.

Complications of Temporary Percutaneous Mechanical Circulatory Support for Cardiogenic Shock: An Appraisal of Contemporary Literature.

Author information

1
Department of Medicine, Mayo Clinic, Rochester, MN, USA.
2
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
3
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA. vallabhajosyula.saraschandra@mayo.edu.
4
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, USA. vallabhajosyula.saraschandra@mayo.edu.

Abstract

Cardiogenic shock (CS) is associated with hemodynamic compromise and end-organ hypoperfusion due to a primary cardiac etiology. In addition to vasoactive medications, percutaneous mechanical circulatory support (MCS) devices offer the ability to support the hemodynamics and prevent acute organ failure. Despite the wide array of available MCS devices for CS, there are limited data on the complications from these devices. In this review, we seek to summarize the complications of MCS devices in the contemporary era. Using a systems-based approach, this review covers domains of hematological, neurological, vascular, infectious, mechanical, and miscellaneous complications. These data are intended to provide a balanced narrative and aid in risk-benefit decision-making in this acutely ill population.

KEYWORDS:

Cardiogenic shock; Complications; Impella; Intra-aortic balloon pump; Mechanical circulatory support; TandemHeart; Veno-arterial extracorporeal membrane oxygenation

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center